Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$205.77 - $233.97 $83,748 - $95,225
-407 Reduced 7.25%
5,204 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$212.32 - $243.58 $693,649 - $795,775
3,267 Added 139.38%
5,611 $1.23 Million
Q2 2022

Aug 15, 2022

BUY
$191.41 - $252.08 $162,315 - $213,763
848 Added 56.68%
2,344 $491,000
Q1 2022

May 13, 2022

BUY
$216.12 - $261.47 $92,931 - $112,432
430 Added 40.34%
1,496 $363,000
Q4 2021

Feb 14, 2022

BUY
$248.03 - $268.66 $264,399 - $286,391
1,066 New
1,066 $278,000
Q1 2019

May 14, 2019

SELL
$91.56 - $117.84 $631,764 - $813,096
-6,900 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$76.11 - $77.2 $525,159 - $532,680
6,900
6,900 $531,000

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $34.7B
More about RMD
Track This Portfolio

Track Hirtle Callaghan & CO LLC Portfolio

Follow Hirtle Callaghan & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.